Related Experiment Video
Updated: Oct 26, 2025

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
[Macrophage migration inhibitory factor meditates MPP+/MPTP-induced NLRP3 inflammasome activation in microglia cells]
1School of Medicine, South China University of Technology, Guangzhou 510006, China.
Objective:
To explore the mechanisms of macrophage migration inhibitory factor (MIF)/nucleus factor-κB (NF-κB) in mediating 1-methyl-4-phenylpyridinium iodide (MPP +)/1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced activation of Nod-like receptor protein 3 (NLRP3) inflammasome in microglials and the its effects on neurons.
Methods:
Murine microglial cell line Bv-2 was infected with a lentivirus carrying MIF shRNA for MIF knockdown and then treated with MPP+. The total protein levels of NLRP3, caspase-1, p65 and p65 in the cell nuclei and cytoplasm were detected. ELISA was used to detect the levels of IL-1β and IL-18 in the culture supernatant, which served as the conditioned culture medium for MN9D cells, whose TH expression level was detected using Western blotting. The effect of stereotactic injection of an adeno-associated virus (AAV) carrying MIF shRNA on behaviors was assessed in a C57BL/6 mouse model of Parkinson disease (PD) induced by intraperitoneal MPTP injection. TH and Iba-1 immunohistochemistry was used to evaluate the number of substantia nigra neurons and the activation of microglia cells, and the protein expressions of MIF, NLRP3 and TH in the substantia nigra were detected with Western blotting.
Results:
MPP+ significantly increased NLRP3 and MIF expressions in Bv-2 cells (P < 0.05). MIF knockdown in Bv-2 cells significantly lowered NLRP3 and caspase-1 protein expressions and IL-1β and IL-18 levels in the culture supernatant (P < 0.05) without affecting total protein level of p65. Bv-2 cells with MIF knockdown showed significantly lowered p65 protein expression in the nuclei but increased p65 expression in the cytoplasm (P < 0.05). The conditioned medium derived from Bv-2 cells with MIF knockdown, as compared with that from than MPP +-treated Bv-2 cells, significantly increased TH expression in MN9D cells (P=0.01). Compared with those in MPTP group, the mice receiving injections of AAV-MIF-shRNA had higher scores in pole test and open field test with lower scores in traction test, and showed increased TH-positive neurons, decreased Iba-1 microglia cell activation, reduced expressions of MIF and NLRP3, and increased expression of TH in he substantia nigra (all P < 0.05).
Conclusion:
Inhibition of MIF can reduce the expression of NLRP3 inflammasomes and inflammatory factor caused by MPP+ in microglia cells to relieve the damage of dopaminergic neurons and alleviate microglia cell activation, thus offering protection against neuroinflammation in Parkinson's disease.
Insights
Inhibiting macrophage migration inhibitory factor (MIF) reduces NLRP3 inflammasome activation in microglia, protecting neurons from Parkinson
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia play a crucial role in neuroinflammation, particularly in Parkinson's disease (PD).
- The Nod-like receptor protein 3 (NLRP3) inflammasome is implicated in microglial activation and neurotoxicity.
- Macrophase migration inhibitory factor (MIF) is a key mediator in inflammatory responses.
Purpose of the Study:
- To investigate the role of MIF/NF-κB signaling in MPP+/MPTP-induced NLRP3 inflammasome activation in microglia.
- To determine the effects of this pathway on dopaminergic neuron damage.
- To evaluate the therapeutic potential of MIF inhibition in a Parkinson's disease model.
Main Methods:
- Utilized murine microglial cell line Bv-2 with MIF knockdown via lentivirus.
- Treated cells and C57BL/6 mice with MPP+ or MPTP, respectively, to induce Parkinson's-like pathology.
- Assessed protein levels (NLRP3, caspase-1, p65, TH), cytokine release (IL-1β, IL-18), and behavioral changes.
Main Results:
- MPP+ treatment increased NLRP3 and MIF expression in microglia.
- MIF knockdown reduced NLRP3 inflammasome activation, pro-inflammatory cytokine release, and protected dopaminergic neuron TH expression.
- In vivo, MIF inhibition improved motor function, increased dopaminergic neurons, and reduced microglial activation in MPTP-treated mice.
Conclusions:
- Inhibition of MIF significantly reduces MPP+-induced NLRP3 inflammasome activation and neuroinflammation in microglia.
- Targeting MIF offers a protective effect against dopaminergic neuron damage.
- MIF inhibition presents a promising therapeutic strategy for neuroprotection in Parkinson's disease.
More Related Videos
06:52Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018